- Home
- HY vs VIR Comparison
HY vs VIR Comparison
Compare HY & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HY
- VIR
- Stock Information
- Founded
- HY 1991
- VIR 2016
- Country
- HY United States
- VIR United States
- Employees
- HY N/A
- VIR N/A
- Industry
- HY Construction/Ag Equipment/Trucks
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- HY Industrials
- VIR Health Care
- Exchange
- HY Nasdaq
- VIR Nasdaq
- Market Cap
- HY 710.8M
- VIR 706.4M
- IPO Year
- HY N/A
- VIR 2019
- Fundamental
- Price
- HY $40.69
- VIR $5.45
- Analyst Decision
- HY Strong Buy
- VIR Strong Buy
- Analyst Count
- HY 1
- VIR 8
- Target Price
- HY $70.00
- VIR $30.25
- AVG Volume (30 Days)
- HY 59.7K
- VIR 1.3M
- Earning Date
- HY 08-05-2025
- VIR 07-31-2025
- Dividend Yield
- HY 3.52%
- VIR N/A
- EPS Growth
- HY N/A
- VIR N/A
- EPS
- HY 5.60
- VIR N/A
- Revenue
- HY $4,162,100,000.00
- VIR $20,861,000.00
- Revenue This Year
- HY N/A
- VIR N/A
- Revenue Next Year
- HY $2.55
- VIR $0.62
- P/E Ratio
- HY $7.30
- VIR N/A
- Revenue Growth
- HY N/A
- VIR N/A
- 52 Week Low
- HY $34.13
- VIR $4.32
- 52 Week High
- HY $84.44
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- HY 46.79
- VIR 53.92
- Support Level
- HY $39.86
- VIR $5.20
- Resistance Level
- HY $41.45
- VIR $6.23
- Average True Range (ATR)
- HY 1.37
- VIR 0.29
- MACD
- HY -0.11
- VIR 0.00
- Stochastic Oscillator
- HY 36.65
- VIR 46.97
About HY Hyster-Yale Materials Handling Inc.
Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally under the Hyster and Yale brand names. The Company has five segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni) and Nuvera Fuel Cells, LLC (Nuvera). Majority of revenue is from Lift Trucks. geographically operates in America, EMEA, JAPIC, maximum revenue from America.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.